Normier G, Pinel A M, Dussourd d'Hinterland L, Wigzell H, Binz H
Céntre d'Immunologie et de Biotechnologie Pierre Fabre, Le Puy St-Martin, St-Julien-en-Genevois, France.
Dev Biol Stand. 1992;77:79-85.
Over the past twenty-five years, many authors have reported evidence of the immunoprotective capacity of ribosomes isolated from bacteria, fungi and parasites. Since 1971 we have explored the protective capacity of ribosomes isolated from a large variety of micro-organisms responsible for human and animal diseases. Accurate biochemical characterization of ribosomes always reveals trace amounts of non-ribosomal components such as short polysaccharides strongly linked to ribosomal RNA after phenol extraction even under denaturing conditions. rRNA-antigen complexes have been purified from Klebsiella pneumoniae ribosomes inducing high level of protection against homologous experimental infection in mice. Monoclonal antibodies raised against ribosomes and then selected for their ability to confer passive immunity to mice have been used to study the mechanism of the protection induced by ribosomes and to characterize their "immunogenic principle". These investigations have clearly shown the presence on ribosomes of epitopes corresponding to antigens normally exposed on the membrane of the bacteria. In the original concept of "ribosomal immunotherapy" that we have developed, ribosomes can be considered as natural carriers for cell surface epitopes, presenting them to the immune system in a highly immunogenic configuration.
在过去二十五年里,许多作者报告了从细菌、真菌和寄生虫中分离出的核糖体具有免疫保护能力的证据。自1971年以来,我们一直在探索从多种引起人类和动物疾病的微生物中分离出的核糖体的保护能力。核糖体的精确生化特性分析总是显示,即使在变性条件下,经苯酚提取后,仍有痕量的非核糖体成分,如与核糖体RNA紧密相连的短多糖。已从肺炎克雷伯菌核糖体中纯化出rRNA - 抗原复合物,其对小鼠同源实验性感染具有高水平的保护作用。针对核糖体产生的单克隆抗体,随后因其赋予小鼠被动免疫的能力而被筛选出来,用于研究核糖体诱导的保护机制并表征其“免疫原性原理”。这些研究清楚地表明,核糖体上存在与通常暴露于细菌膜上的抗原相对应的表位。在我们所发展的“核糖体免疫疗法”的最初概念中,核糖体可被视为细胞表面表位的天然载体,以高度免疫原性的构型将它们呈递给免疫系统。